Search Results - "Zong, Alice"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Development of a quantitative relationship between CAR-affinity, antigen abundance, tumor cell depletion and CAR-T cell expansion using a multiscale systems PK-PD model by Singh, Aman P, Zheng, Xirong, Lin-Schmidt, Xiefan, Chen, Wenbo, Carpenter, Thomas J, Zong, Alice, Wang, Weirong, Heald, Donald L

    Published in mAbs (01-01-2020)
    “…The development of mechanism-based, multiscale pharmacokinetic-pharmacodynamic (PK-PD) models for chimeric antigen receptor (CAR)-T cells is needed to enable…”
    Get full text
    Journal Article
  2. 2

    Bench‐to‐bedside translation of chimeric antigen receptor (CAR) T cells using a multiscale systems pharmacokinetic‐pharmacodynamic model: A case study with anti‐BCMA CAR‐T by Singh, Aman P., Chen, Wenbo, Zheng, Xirong, Mody, Hardik, Carpenter, Thomas J., Zong, Alice, Heald, Donald L.

    “…Despite tremendous success of chimeric antigen receptor (CAR) T cell therapy in clinical oncology, the dose‐exposure‐response relationship of CAR‐T cells in…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis: the Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial by Dunn, James P, Van Natta, Mark, Foster, Gregory, Kuppermann, Baruch D, Martin, Daniel F, Zong, Alice, Jabs, Douglas A

    Published in Retina (Philadelphia, Pa.) (01-02-2004)
    “…To describe the complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis. Prospective data collection within the context of a…”
    Get full text
    Journal Article
  7. 7

    Development of a quantitative relationship between CAR-affinity, antigen abundance, tumor cell depletion and CAR-T cell expansion using a multiscale systems PK-PD model by Singh, Aman P., Zheng, Xirong, Lin-Schmidt, Xiefan, Chen, Wenbo, Carpenter, Thomas J., Zong, Alice, Wang, Weirong, Heald, Donald L.

    Published in mAbs (01-01-2020)
    “…The development of mechanism-based, multiscale pharmacokinetic-pharmacodynamic (PK-PD) models for chimeric antigen receptor (CAR)-T cells is needed to enable…”
    Get full text
    Report